Related Experiment Video
Updated: Aug 12, 2026
Isolation of Adult Spinal Cord Nuclei for Massively Parallel Single-nucleus RNA Sequencing
Published on: October 12, 2018
Early results using the nucleus CI24M in children
N L Cohen1, S B Waltzman, J T Roland
1Department of Otolaryngology, New York University School of Medicine, New York 10016, USA.
Insights
Children receiving the Nucleus CI24M cochlear implant showed significant improvements in speech recognition. Early results indicate this device offers substantial benefits for pediatric hearing rehabilitation.
Area of Science:
- Otolaryngology
- Biomedical Engineering
- Pediatric Audiology
Background:
- Cochlear implantation is a vital treatment for severe to profound sensorineural hearing loss in children.
- The Nucleus CI24M device represents a significant advancement in auditory prosthetics.
Purpose of the Study:
- To evaluate the early speech recognition outcomes in pediatric patients implanted with the Nucleus CI24M cochlear implant.
- To assess the efficacy of the Nucleus CI24M in improving auditory perception in children.
Main Methods:
- A cohort of 19 congenitally deaf children (aged 20 months to 15 years) received the Nucleus CI24M.
- Speech perception was assessed pre- and post-implantation using a comprehensive battery of standardized tests, including ESP, GASP, PBK, Common Phrases, MLNT, LNT, and BKB.
Main Results:
- Statistical analysis revealed significant improvements in open-set speech recognition abilities in children who could complete the assessment tasks.
- These findings suggest a positive impact of the cochlear implant on speech perception.
Conclusions:
- The Nucleus CI24M cochlear implant demonstrates significant benefits for children with hearing loss.
- Short-term use of the Nucleus CI24M leads to measurable improvements in speech recognition, highlighting its effectiveness in pediatric auditory rehabilitation.
Objective:
To report early postimplantation speech recognition results in children who received Nucleus CI24M cochlear implants.
Study Design:
The study group consisted of 19 consecutively implanted children.
Patients And Setting:
Congenitally deaf children (20 months to 15 years old) were implanted with the Nucleus CI24M and followed-up at New York University Medical Center for a period of 3 to 12 months.
Main Outcome Measures:
Speech perception was evaluated preoperatively and postoperatively using the Early Speech Perception (ESP) test, the Glendonald Auditory Screening Procedure (GASP) word and sentence tests, Phonetically Balanced Kindergarten (PBK) monosyllabic word lists, Common Phrases test, the Multisyllabic and Lexical Neighborhood (MLNT, LNT) tests, and the Banford-Kowal-Bench (BKB) sentence test.
Results:
One-way analyses of variance revealed significant improvement in open-set speech recognition in children able to perform measurement tasks.
Conclusions:
The Nucleus CI24M cochlear implant provides significant benefit to children after short-term use.
